TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Linical Co., Ltd. ( (JP:2183) ) has provided an update.
Linical Co., Ltd. reported a significant decline in its financial performance for the fiscal year ending March 31, 2025, with net sales dropping by 15.2% and a net loss of ¥539 million. Despite the downturn, the company forecasts a recovery in the next fiscal year with an expected 7.3% increase in net sales and a return to profitability.
More about Linical Co., Ltd.
Linical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the clinical research industry. It focuses on providing services related to drug development and clinical trials, catering to the pharmaceutical and biotechnology sectors.
Average Trading Volume: 50,056
Technical Sentiment Signal: Sell
Current Market Cap: Yen6.71B
See more data about 2183 stock on TipRanks’ Stock Analysis page.